Christopher Starr

Christopher M.
Starr was the founder of Horizon Pharmaceutical LLC, founded in 2009, serving as Independent Director from 2015 to 2016.
Dr. Starr is the founder of Monopar Therapeutics, Inc., founded in 2014, serving as Executive Chairman since 2014.
Dr. Starr was the founder of BioMarin Pharmaceutical, Inc., founded in 1997, serving as Chief Scientific Officer & VP-R&D.
Dr. Starr was the founder of Raptor Pharmaceuticals Corp., founded in 2005, serving as Director from 2014 to 2016.
Current jobs include Chief Executive Officer at Raptor Discoveries, Inc. since 2005, Chairman at Thiogenesis Therapeutics, Inc., and Chairman at Thiogenesis Therapeutics Corp.
since 2022.
Former jobs include Executive Chairman at Glycomine, Inc. in 2016, Vice President-Research & Development at Glyko, Inc. from 1991 to 1998, and Associate at The National Research Council and National Institutes of Health.
Education includes a doctorate from SUNY Upstate Medical University and an undergraduate degree from Syracuse University.